Related by context. All words. (Click for frequent words.) 78 Mr. Karbe 71 Daniel Junius 69 Carl Spana Ph.D. 69 Dr. Manuso 68 Georges Gemayel 68 Mr. Kriegsman 68 Dr. Damaj 67 Harry Palmin President 67 subsidiaries visit http:/www.apricusbio.com 66 Drew Fromkin President 66 Mr. Armando Anido 66 Howard H. Pien 66 please visit http:/www.sunesis.com 66 BioCentury Future Leaders 66 Dr. Blobel 66 Inc EXEL 66 Mitchel Sayare 66 Naglazyme R 66 Robert L. Bratzler 66 Alexis Borisy President 66 Alton Boynton 65 Martin Nicklasson 65 TRACON Pharmaceuticals 65 LibiGel ® testosterone gel 65 serine protease inhibitor CU# 65 Nasdaq IDRA today 65 Ron Bentsur 65 BIO InvestorForum 65 Stephen Ghiglieri 65 Juergen Engel Ph.D. 64 www.vivus.com 64 CombinatoRx Incorporated 64 Ulrich Dauer CEO 64 Lauren Silvernail 64 Nasdaq INCY 64 Neil K. Warma 64 Syndax 64 Jean Pierre Sommadossi Ph.D. 64 Inc. NASDAQ EXEL 64 Mr. Bentsur 64 ENZON 64 Roland Haefeli 64 Kathleen Danenberg 64 H. Willard Flamel 64 Lonnie Moulder 64 Isis Pharma 64 Dr. Marlies Sproll 64 please visit www.dyax.com 63 Dr. Stylli 63 Genitope Corporation 63 Alder Biopharmaceuticals 63 Alnylam #x# 63 please visit http:/www.atherogenics.com 63 DPX Survivac 63 Spiro Rombotis President 63 Vaughn M. Kailian 63 Kazumi Shiosaki 63 Mihael Polymeropoulos MD 63 Nasdaq IDRA 63 Inc. NASDAQ ZLCS 63 EnVivo 63 Inc. Nasdaq TNGN 63 t2cure GmbH 63 Dr. Aiping Young 63 please visit www.advaxis.com 63 Duncan Higgons 63 please visit http:/www.supergen.com 63 Genaera Corporation 63 NPS Pharma 63 OTC BB PVCT 63 Epiphany Biosciences 63 Jeremy Curnock Cook 63 Intarcia Therapeutics 63 Inc. NASDAQ ICGN 63 Nasdaq IMGN 63 Nasdaq NPSP 63 Tomas Leanderson 63 James Manuso 62 Dan Passeri 62 Dr. Cauwenbergh 62 visit www.targanta.com 62 Nasdaq ONXX today 62 BioGeneriX 62 Yves Rosconi President 62 Hakan Edstrom 62 Sunesis Pharmaceuticals 62 Martin Gerstel 62 Alvine Pharmaceuticals 62 Daniel Passeri Curis 62 Dr. Yatscoff 62 NASDAQ GPCB today 62 Etubics 62 Joshua Boger Ph.D. 62 www.micromet inc.com 62 Donald L. Drakeman 62 romazarit 62 George Scangos 62 Scangos 62 Conatus Pharmaceuticals 62 Neuraltus 62 Nasdaq INCY announced 62 Sylvie Gregoire 62 MultiCell Technologies 62 Dicerna 62 Dr. Horst Zerbe 62 Inc. Nasdaq IMGN 62 SinuNase ™ 62 Dave Holveck 62 deforolimus 62 ERYtech 62 H. Carrel 62 Oxxon 62 CFO Ilan Daskal 62 http:/www.amylin.com 62 Dr. Arndt Schottelius 62 Xanthus Pharmaceuticals Inc. 62 Agios Pharmaceuticals 62 James SJ Manuso 62 TLR antagonists 62 BTG plc 62 Trubion Pharmaceuticals TRBN 62 SCOLR Pharma 62 Trubion Pharma 62 NASDAQ PCYC 62 programs visit http:/www.bionovo.com 62 Edward M. Rudnic 61 ILEX Oncology 61 Therapeutic Competitors companiesandmarkets.com adEgemonye 61 Dr. Shrotriya 61 Mark Pykett 61 FoldRx 61 William H. Rastetter 61 RIGScan CR 61 Adnectin 61 Vicente Anido Jr. 61 AVEO Pharmaceuticals 61 Nancy Wysenski 61 Igor Gonda Ph.D. 61 Faheem Hasnain 61 Anat Cohen Dayag 61 www.lexpharma.com 61 Adventrx 61 Sutro Biopharma 61 Anthony Giovinazzo 61 FoldRx Pharmaceuticals Inc. 61 Hedgehog antagonist 61 Igeneon 61 PsychoGenics 61 Alantos 61 Inc Therapeutic Competitors 61 Paul Laikind 61 Arno Therapeutics 61 THR beta agonist 61 Syntonix 61 proprietary capillary aerosolization 61 Steven B. Ratoff 61 Metabasis Therapeutics Inc. 61 PhaseBio 61 http:/www.viropharma.com 61 Michael Tzannes 61 novel therapeutic antibodies 61 Laura Brege 61 http:/www.pvct.com 61 symbol AVXL 61 HemaQuest 61 Safi Bahcall Ph.D. 61 TOPIGEN 61 Amir Avniel 61 please visit www.medicinova.com 61 Receives Milestone Payment 61 Per Olof Wallström 61 Vaccinex 61 Q4 Profit Decreases 61 Diasome 61 NASDAQ DYAX 61 oncology therapeutics 61 Surfaxin LS 61 Pierre Larochelle 61 Ph.D. Targacept 61 Barry D. Quart 61 Neosil 61 J.P. Morgan Healthcare 61 Salmedix 61 Corp. www.anavex.com 61 Ariad Pharma 61 Frank Karbe 61 VentiRx 61 Calistoga Pharmaceuticals 60 NASDAQ ARRY 60 FOLOTYN ® 60 glucokinase activator 60 Hematide ™ 60 HuMax TAC 60 Announces Poster Presentations 60 Kirsten Drejer 60 Celator 60 tiapamil 60 Corporation GENZ GENZ 60 molecular chaperone regulation 60 NASDAQ INFI 60 Nasdaq PARD biopharmaceutical 60 Idera Pharmaceuticals 60 Syntonix Pharmaceuticals 60 Hoji Alimi 60 Vincent Mutel CEO 60 Inc. NASDAQ ACUS 60 adrenergic regulation 60 Joseph Gersuk 60 Nasdaq CYCC Nasdaq CYCCP 60 Inc. Nasdaq INFI 60 Biomarin 60 Christopher Anzalone Arrowhead 60 Bayhill Therapeutics 60 BioFocus DPI Galapagos 60 Addex Pharmaceuticals SWISS ADXN 60 JJ Finkelstein 60 Kevin Hrusovsky President 60 ORTHOCON 60 Ardea Biosciences 60 visit http:/www.mannkindcorp.com 60 Lexicon Pharmaceuticals 60 Joanna Horobin MD 60 NASDAQ MYGN 60 Cyclacel Pharmaceuticals 60 J. Mazzo Ph.D. 60 VIRxSYS 60 http:/www.sunesis.com 60 Galenea 60 Mark Leuchtenberger 60 please visit http:/www.vandapharma.com 60 initiated Phase 1b 60 Inc. Nasdaq NSTK 60 Kleanthis G. Xanthopoulos Ph.D. 60 Teplizumab 60 Dr. LaMattina 60 Receptos 60 apricitabine ATC 60 Alnylam Nasdaq ALNY 60 Tod Woolf Ph.D. 60 ThromboGenics commenting 60 Nasdaq SGEN 60 take decission unanimously 60 Inc. Nasdaq MLNM 60 Swisher Sunesis 60 Radu Leca 60 candidate CRLX# 60 Nasdaq VRTX 60 Visit www.BASInc.com 60 Pathway Diagnostics 60 Marc Oczachowski 60 Catalyst Biosciences 60 Laurent Condomine 60 Carnecchia 60 MBRX 60 Ampio 60 Ken Howling 60 ActivX 60 Stuart Essig Integra 60 NormOxys 60 Regeneron Pharma 60 CyDex Pharmaceuticals 60 AEterna Laboratories 60 Judy C. Lewent 60 Biolipox 60 Joshua Boger 60 Bellicum Pharmaceuticals Inc. 60 Alex Kotzer 60 Vaughn Kailian 60 QuatRx 60 NASDAQ LGND 60 Cascade LifeSciences 60 ASX PGL 60 Progenics Pharmaceuticals 60 Dani Bolognesi 60 Dr. Avtar Dhillon 60 Keith Katkin 60 Kosan dependence 60 Dr. Laikind 60 Potelligent Technology 60 Antisense Pharma GmbH 60 Athena Neurosciences 60 Dr. Masamichi Koike 60 Nasdaq LEXG 60 Uli Hacksell Ph.D. 60 Miravant 60 Mr. Ellberger 60 Tacere 60 targeted anticancer biopharmaceuticals 60 Leiden MD Ph.D. 60 Enzon Pharmaceuticals Inc 60 Nasdaq IDIX 60 Nasdaq RXII 60 cosmetic cosmeceutical products 60 Selecta Biosciences 60 Dr. Gamzu 60 Catabasis 60 Nicholas Landekic President 60 Psivida 60 Loïc Maurel MD 60 Sven Andreasson 59 Ascent Therapeutics 59 HepeX B TM 59 Submits Response 59 website www.novavax.com 59 Inc. Nasdaq AVII 59 NeoGenesis 59 Rhein Biotech GmbH 59 Revotar 59 novel trazodone formulation 59 Hedgehog Pathway Inhibitor 59 Nasdaq MNKD 59 AMEX REX 59 Initiates Enrollment 59 antibacterial therapeutics 59 Loic Maurel 59 Acumen BioFin Rodman 59 Ivan Gergel MD 59 Nasdaq HALO biopharmaceutical 59 visit http:/www.neogenomics.org 59 TNGN 59 Sol J. Barer 59 E Winningham 59 Ms. Falberg 59 Lisa Krinsky 59 NASDAQ INGN 59 Nanobody R 59 Ambit Biosciences 59 John F. Thero 59 Cambria Biosciences 59 Bruce Galton 59 Viventia Biotech 59 NASDAQ ABII 59 OTCBB PYTO 59 Herm Rosenman 59 NASDAQ PGNX 59 NASDAQ IMCL 59 Louis Drapeau 59 BioCentury NewsMakers 59 CEO Tod Woolf 59 Innovive Pharmaceuticals 59 Nereus Pharmaceuticals 59 Dr. Philip Toleikis 59 NASDAQ FLML 59 Chimigen TM 59 AVXL 59 Rosen ViroPharma 59 WILEX 59 Inc. Nasdaq ICGN 59 Phytomedics Inc. 59 Mr. Keltjens 59 Dr. Halvor Jaeger 59 Adrian Hobden Ph.D. 59 Christian Itin 59 Xcytrin R 59 tramiprosate Alzhemed TM 59 Aegera 59 Jean Jacques Bienaime 59 AMEX ISV 59 Nasdaq ENZN 59 NASDAQ VRTX 59 Ceflatonin R 59 Nasdaq DVAX 59 Aerovance 59 NASDAQ CYTX 59 Dr. Fahar Merchant 59 Eran Broshy 59 Nasdaq ANDS 59 www.epixpharma.com 59 Idenix Pharmaceuticals 59 CeNeRx BioPharma 59 immatics 59 Metaphore 59 EHT AGN 59 MD Halozyme 59 Pedro Lichtinger 59 Ralph Makar 59 Neogenix 59 HepeX B 59 Mr. Rosconi 59 ASGCT 59 Mr. Pilnik 59 Errol De Souza 59 Dr. Kshitij Mohan 59 MerueloMaddux 59 Patrice Milos 59 David Aviezer 59 AIM SLN Silence 59 Patrick Balthrop 59 Xenon Pharmaceuticals 59 Nitric Bio 59 Alnara 59 NOBEX 59 Paris IPN 59 allosteric modulation 59 Sheldon Berkle 59 Declan Doogan 59 CobaCyte 59 Burt Adelman 59 Synageva BioPharma Corp. 59 Inc. Nasdaq EXEL 59 Dynogen 59 Creabilis Therapeutics 59 AERx iDMS 59 Michael V. Novinski 59 Ms. Lewent 59 CRMD# 59 RenaMed 59 Jeff Morhet Chairman 59 Michael H. Carrel 59 Mark G. Foletta 59 please visit www.middlebrookpharma.com 59 Butchofsky 59 Mr. Luc Mainville 59 assumes noobligation 59 KAI Pharmaceuticals 59 Initiates Clinical 59 NASDAQ AVEO 59 Addex Pharmaceuticals Ltd. 59 www.innovaro.com 59 Adenosine Therapeutics 59 SafeStitch Medical 59 Polymeropoulos 59 Inc. OTCBB CYKN 59 Vincent Milano ViroPharma 59 Inhale Therapeutic Systems 59 Craig Tooman 59 Cardiovascular Therapeutics 59 Jeffrey Buchalter 59 Duffy DuFresne 59 GENR 58 Rik Deitsch 58 PDE# inhibitors 58 Dr. Randall Yatscoff 58 Receives Orphan Drug 58 Steven R. Deitcher 58 seliciclib CYC# 58 Carl Spana 58 George Scangos Ph.D. 58 Mihael H. Polymeropoulos MD 58 Greg Pendura 58 ZaBeCor 58 Semafore 58 Jinsheng Ren 58 Auxilium Pharma 58 Bugg Ph.D. 58 LensAR 58 leading oral taxane 58 Dr. Maraganore 58 novel peptides 58 Mark Leuchtenberger President 58 Urocortin 2 58 Nasdaq MBRX announced 58 Mr. Bienaime 58 Frederic Lemoine 58 Francis DiNuzzo 58 Tom van Aken 58 Ofer Gneezy 58 AMEX TTP 58 Enzo Therapeutics 58 Antony Koblish President 58 Dale Pfost 58 Dr. Siegall 58 Quark Pharmaceuticals 58 Zosano 58 RGIN 58 Dino Dina 58 Anavex 58 Nasdaq CGEN 58 commented Mitchel Sayare 58 Jesse Blout San Francisco 58 www.aastrom.com 58 Jean Pierre Sommadossi 58 Arcxis Biotechnologies 58 confirmatory pivotal 58 Dr. Sirgo 58 Relypsa 58 Friesen PhD 58 NASDAQ RNAI 58 Callisto Pharmaceuticals 58 Michael Fonstein Ph.D. 58 Eric L. Dobmeier 58 Biomoda www.biomoda.com 58 Lars Ekman 58 Quay MD Ph.D. 58 epigenetic therapies 58 antisense therapeutics 58 Sylvie Gregoire President 58 Epizyme 58 Eckard Weber 58 Incyte Corporation 58 BioMS Medical 58 Robin Stracey 58 George Migausky 58 Teikoku Pharma USA 58 Sulonex TM 58 investigational compounds 58 naronapride 58 ARISE Phase III 58 Harold Van Wart 58 Poyhonen 58 Nasdaq DYAX 58 Raven Biotechnologies 58 NeutroSpec TM 58 Clay Siegall 58 LEAD Therapeutics 58 KRYSTEXXA TM pegloticase 58 technology visit http:/www.genmab.com 58 SUTENT ® 58 Igor Gonda 58 Mark A. Sirgo 58 Joe Carleone 58 BioContact 58 CAMPATH 58 EpiTherapeutics 58 P#X# antagonist 58 Elkan Gamzu Ph.D. 58 Inc. Nasdaq NEOL 58 Nasdaq LXRX 58 Tovaxin TM 58 Gastrotech 58 aptamer therapeutics 58 Peter D' Aloia 58 technological innovations adversely affecting 58 Apexigen 58 AB OMXS BINV 58 Amarantus 58 M.D. Ph.D. 58 Peptimmune 58 Ken Cragun 58 Nasdaq IDRA biotechnology 58 myasthenia gravis Huntington 58 Gilles Gagnon 58 Dr. Isa Odidi 58 Carl A. Pelzel 58 Thomas CK Yuen 58 manufactures minimally invasive 58 Ostabolin C TM 58 Amylin Eli Lilly 58 Biogen NASDAQ BIIB 58 Odyssey Thera 58 Presents Preclinical Data 58 rxRNA 58 Joseph Feczko 58 Excaliard 58 http:/www.unigene.com 58 www.vicortech.com 58 Ore Pharmaceuticals 58 BioRexis 58 IG HCR ;) CO 58 BioSante Pharmaceuticals NASDAQ BPAX 58 Arqule 58 Tranzyme Pharma 58 Transcept Pharmaceuticals 58 Inc. NASDAQ SGEN 58 Inflazyme 58 Gearóid Faherty Chairman 58 ZFP Therapeutics 58 EnzymeRx 58 NASDAQ ALNY 58 pathologists oncologists hospitals 58 VCRT 58 REGiMMUNE 58 OTCBB IMNR 58 ThermoDox ® clinical 58 Gregory D. Casciaro 58 Printable slides 58 Inotek Pharmaceuticals Corporation 58 Alligator Bioscience AB 58 Nasdaq THRX 58 Demopulos 58 Narachi 58 Nasdaq NBIX 58 BIOCOM Investor Conference 58 Amylin Pharma 58 commented Alexis Borisy 58 visit www.virtualscopics.com 58 Karin Eastham 58 NTII 58 miRNA therapeutics 58 Inc. NASDAQ IDMI 58 Derek Hennecke 58 PEG SN# 58 strategy summarization 58 BioFinance 58 Stromedix 58 J. Donald deBethizy 58 trastuzumab DM1 T DM1 58 www.spectrumpharm.com 58 ECTE 58 Akesis Pharmaceuticals 58 Regado Biosciences 58 Presents Preclinical 58 Chief Executive Lamberto Andreotti 58 Provectus Pharmaceuticals specializes 58 Preclinical Development 58 Expands Scientific Advisory 58 PharmD Ardea 58 Simon Sturge 58 Sygnis 58 Panzem R NCD 58 Dr. Gussak 58 unique PER.C6 58 enGene 58 Archexin 58 Aegera Therapeutics 58 Ms. Katen 58 James S. Manuso 58 Tim Mayleben 58 Jordan Estra 58 please visit www.metabolon.com 58 Alnara Pharmaceuticals 58 AGY Therapeutics 58 Annual BIO 58 Mr. Jassawalla 58 Alnylam Biotherapeutics 58 MEDAREX 58 Tibotec BVBA 58 Bruno Tocque 58 Philip Astley Sparke 58 Anchor Therapeutics 58 website http:/www.celsion.com 58 NASDAQ ENMD 58 Dr Werner Lanthaler 58 DsiRNA molecules 58 Ultrafast Insulin 58 WILEX AG 58 Chemokine Therapeutics 58 Inc. NASDAQ SNUS 58 www.enbridge.com investor 58 Lycera 58 Proteostasis 58 Biotica 58 Mersana 58 Altair Therapeutics 58 successfully commercialize Iluvien 58 Evoltra ® 58 MacroChem Corporation 58 midstage clinical 57 Philippe Calais 57 Martin Madaus 57 Garo H. 57 Inc SPPI 57 Damian Marron 57 CysDisplay 57 MDxHealth 57 Array BioPharma 57 RAPTIVA r 57 Kiadis 57 P. Luci 57 Senesco Technologies 57 Nasdaq EMIS 57 Garnet Biotherapeutics 57 Apricus Bio 57 Chronogen 57 Oasmia 57 http:/www.pdi-inc.com 57 Jens Schneider Mergener 57 Canaccord Adams Hepatitis C 57 EnVivo Pharmaceuticals 57 LentiVector technology 57 Fran DiNuzzo 57 Inc. NASDAQ EVVV 57 Nasdaq LXRX biopharmaceutical 57 Cytta Corp. 57 MD Geron 57 Ron Najafi 57 Barry Selick 57 novel MetAP 2 57 euro adhoc Intercell AG 57 Procyon Biopharma 57 Numoda 57 Nasdaq PHRM 57 Anders Ekblom 57 Dr. Anil Diwan 57 Mark Emkjer 57 Rolf Classon 57 Yves Rosconi 57 JJ Finkelstein RegeneRx 57 Emisphere Technologies 57 Wayne T. Hockmeyer 57 William Freytag 57 Lac Carling Testimonial 57 Patrick J. Balthrop 57 Melior Discovery 57 Lexicon Genetics 57 Cerimon Pharmaceuticals Inc. 57 stated Dominique Costantini 57 NuRx 57 Urigen Pharmaceuticals 57 SEQUENOM 57 A. Sedor 57 Nasdaq ALNY 57 Christoph Westphal MD Ph.D. 57 L. Enns 57 Quark Biotech Inc. 57 Joseph K. Belanoff 57 NASDAQ REGN 57 Opsona Therapeutics 57 Hoyoung Huh MD Ph.D. 57 Volker Whiting 57 Onno van de Stolpe 57 Inc. NASDAQ HEPH 57 Zemiva TM 57 Hoyoung Huh 57 Genta Incorporated OTCBB GETA 57 Cortria 57 IRX Therapeutics 57 Eamonn Hobbs 57 NULCF 57 NNR Therapeutics 57 Alnylam Pharma 57 Mark Schaftlein 57 PHX# 57 Anaphore 57 Remi Barbier 57 Aurora Biosciences 57 OGeS 57 www.zecotek.com 57 Paolo Pucci chief 57 OTCBB CVBT 57 Sirtris GSK 57 ViOptix 57 Ms. Stancic 57 Henry F. Blissenbach 57 novel anti infective 57 Dr. Gulfo 57 Enanta Pharmaceuticals 57 ulimorelin 57 Metabasis Therapeutics 57 NASDAQ BDSI 57 Glen de Vries 57 Agenus 57 Xytis 57 Tetraphase 57 Æterna Zentaris 57 Amplimmune 57 Neogenix Oncology 57 Company Report companiesandmarkets.com 57 Zami Aberman 57 Q3 Loss Narrows 57 Jack Abuhoff Chairman 57 Cerus Corporation 57 Virdante 57 Actelion Pharmaceuticals Ltd. 57 ESBATech 57 including eniluracil ADH 57 Dennert O. Ware 57 Taglich Brothers Initiates Coverage 57 John Hlywak 57 NasdaqGM SPPI 57 Jim Sulat 57 visit www.bioject.com 57 Jean Luc Belingard 57 TESARO 57 Quark Biotech 57 H3 Biomedicine 57 ESBATech AG 57 Nasdaq OPTR 57 Mihael Polymeropoulos 57 NeurAxon Inc. 57 PharmaFrontiers 57 alvespimycin 57 NASDAQ NOVN today 57 Dr. Agarwala 57 ProlX 57 Cerexa Inc. 57 Philippe Gribeauval President 57 Matt Emmens 57 Jal S. Jassawalla 57 visit www.novabaypharma.com 57 John Lechleiter Ph.D. 57 Nasdaq RDEA 57 Q1 Profit Decreases 57 Fibrocell 57 Patrick Fourteau 57 Edward T. Shonsey 57 Proacta 57 Karo Bio 57 Haim Aviv 57 Completes Patient Enrollment 57 Lorus Therapeutics 57 elbion 57 Lars Kongsbak 57 Diatos SA 57 Protalex Inc. 57 AIMM trial 57 Peer Schatz QIAGEN 57 Pramod Bhasin Genpact 57 Altus Pharmaceuticals 57 strategy GlobalData summarization 57 Opexa 57 ProFibrix 57 elotuzumab 57 Cenomed 57 Trellis Bioscience 57 MKC# MKC# PP 57 Nasdaq ARRY 57 ongoing Phase IIIb 57 Inflazyme Pharmaceuticals 57 Frank Verwiel MD 57 NASDAQ CYPB 57 William Rastetter 57 Glenn A. Oclassen 57 Dr. Ayalew Tefferi 57 Dr. Ornskov 57 Sirius Genomics 57 CeNeS Pharmaceuticals plc 57 TissueInformatics 57 Aptuit Informatics 57 Justin Belobaba President 57 Jean Loup Romet 57 NASDAQ INCY 57 molecular imaging radiopharmaceutical 57 Frank A. Lodzinski 57 AEterna 57 Timo Veromaa 57 Brad Bolzon 57 Mersana Therapeutics 57 CoMentis 57 Metabolex 57 initiate Phase IIb 57 Hybridon 57 TransVax TM 57 Adelene Q. Perkins 57 Tikvah Therapeutics 57 FivePrime 57 compound INCB# 57 Jan Keltjens President 57 Angelo C. Malahias 57 Caleco Pharma 57 HDL Mimetic Peptide 57 Avila Therapeutics 57 Forma Therapeutics 57 sirtuin therapeutics 57 Power3 Medical 57 HaptoGuard 57 Brussels THR 57 Sunesis Pharmaceuticals Inc. 57 Bioaccelerate compounds under 57 Zelos Therapeutics 57 Explores Strategic Alternatives 57 Targeted Chemotherapy 57 dermatology therapies 57 Bradbury Amylin 57 HEPLISAV ™ 57 Velcura Therapeutics 57 Eric Bjerkholt 57 Frankfurt XMP 57 Kuslima Shogen 57 Avtar Dhillon MD 57 James DeOlden 57 Deborah Dunsire MD 57 Philippe Archinard 57 ImmunoVaccine Technologies 57 Singulex 57 Upcoming Investor Presentations 57 Wabschall 57 Tragara Pharmaceuticals Inc. 57 K. Wotton 57 Migenix 57 Neil Flanzraich vice 57 Chemokine 57 Tranzyme 57 Partnering Agreements 57 Fereydoun Firouz 57 Juan Vegarra Chairman 57 AMEX RGN 57 Somanta 57 NRGN 57 Elixir Pharmaceuticals 57 Morhet 57 Omthera 57 immunotherapeutic approaches 57 ACLARA 57 Q2 Loss Narrows 57 FluoroPharma 57 Taligen 57 Zuerblis 57 Oli Steindorsson 57 Inotek 57 TACI Ig 57 Maraganore 57 www.clenergen.com 57 Michael Liik 57 TapImmune 57 Bionutrics 57 NASDAQ ALTH 57 David Sidransky 57 Intarcia 57 NASDAQ KOSN 57 Seattle Genetics SGEN 57 Hollings Renton 57 oral picoplatin 57 Don deBethizy 57 staphylococcal vaccines 57 J. Barberich 57 NovaCal 57 Biogen Nasdaq BIIB 57 Ambrx 57 Joern Aldag President 57 Ziopharm 57 Fred Eshelman chief 57 Proteon Therapeutics 57 CardioVascular BioTherapeutics Inc. 56 NASDAQ ARIA 56 recombinant biopharmaceutical 56 http:/www.vrtx.com 56 ANAVEX 56 Prolexys 56 www.aveopharma.com 56 Bassil Dahiyat Ph.D. 56 Enanta 56 Protalex 56 NASDAQ ONXX 56 TransVax tm 56 TSX ONC NASDAQ ONCY 56 Jeffrey H. Buchalter 56 zileuton IV 56 http:/www.appliedbiosystems.com/ 56 please visit www.rexahn.com 56 Welcomes Analyst Initiation 56 Hana Biosciences 56 Dr. Henrich Guntermann 56 BioContact Quebec 56 Craig Tuttle Transgenomic 56 Mr. Melnuk 56 Phase IIb clinical trials 56 Celator Pharmaceuticals 56 Steve Worland Ph.D. 56 NYSE Amex PTN 56 Pervasis 56 Jacob Inbar 56 Inc. Nasdaq HGSI 56 Friedhelm Blobel 56 Aoxing Pharma 56 DOV Pharmaceuticals 56 Spiro Rombotis 56 FORMA Therapeutics 56 Illumigen 56 Ulf Wiinberg 56 Applied NeuroSolutions 56 ALN PCS 56 Intellect Neurosciences 56 COO Exercises Options 56 visit www.exobox.com 56 Cardiokine 56 Mr. Yves Rosconi 56 www.quintiles.com 56 KYTHERA 56 Hans Joachim Lohrisch 56 Pharmion Corporation 56 Isotechnika Pharma 56 BioLife Solutions 56 Beats Estimates Analyst Blog 56 Dr. Ash Rofail 56 RNA therapeutics 56 Mr. Mordock 56 Tarek Sherif CEO 56 XTLbio 56 Molecular Templates 56 BioTherapeutics 56 BioSeek 56 Personalized Immunotherapy 56 Cutanea Life Sciences 56 therapeutic monoclonal antibodies 56 SNS# T 56 Murray Tekmira 56 AcryMed Incorporated 56 Curon Medical 56 Cylene Pharmaceuticals 56 DOBI Medical 56 Advanced Biotherapy 56 Allovectin 7 r 56 Cerimon 56 Alexis Borisy 56 InNexus Biotechnology 56 LIFE TECH 56 Slides accompanying 56 Gemin X Biotechnologies 56 Inc. Nasdaq VRUS 56 Edward Lanphier Sangamo 56 Richard J. Meelia 56 Inc. Nasdaq SGEN 56 selective androgen receptor modulators 56 Nicholas Landekic 56 PLK1 SNALP 56 Ms. Gerri Henwood 56 Predictive medicine 56 AMEX DDD 56 Al Altomari 56 Proventys 56 DiaKine 56 Rinat Neuroscience 56 Initiates Phase II 56 PETER PASSI covers 56 Frank Baldino Jr. 56 Q2 Profit Decreases 56 Elusys Therapeutics 56 Nasdaq INHX